Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of Wegovy, and for many people it arrives within the first few days of a new pen or a dose increase. It usually settles. The NHS notes that gastrointestinal symptoms like nausea, vomiting and indigestion are expected, typically most noticeable at the start of treatment or after a step up, and often ease within days to a couple of weeks. The real question isn't whether the nausea is normal — for most people, it is — but what to do next: push through, adjust your habits, or talk to your prescriber. That decision is worth making carefully, and this page walks through the factors.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors, which are found not only in the pancreas but along the gut wall and in brain regions that regulate appetite and satiety. One of the drug's intended effects is slowing gastric emptying, food moves through the stomach more slowly, which helps you feel full for longer. That same mechanism is what produces nausea. The stomach, in effect, is being asked to work differently from how it has always worked, and the adjustment period is real.
The nausea tends to peak in the first week or two after starting a new dose and then gradually quietens. Most people find it manageable by the time their next dose step arrives. The NHS semaglutide medicines page lists nausea, vomiting, diarrhoea, constipation, indigestion and burping as the common effects, noting they are most noticeable early in treatment. That pattern (prominent at first, then fading) is consistent with what the clinical trials reported and with what prescribers see in practice.
It's worth knowing that everyone's baseline is different. People who already have a sensitive stomach, those who eat larger meals, and those who progress through doses quickly tend to report more nausea. That's not a failure, it's information your prescriber can use.
Before concluding that Wegovy doesn't suit you, it's worth ruling out the dietary triggers that amplify nausea significantly. Eating a large meal on injection day is one of the most consistent culprits. High-fat foods, heavy sauces and fried food slow gastric emptying further on top of what the medicine is already doing, and the compounded effect can tip you from mildly queasy into genuinely miserable. Eating quickly, lying down shortly after meals, and drinking carbonated drinks are all worth reviewing.
Practical adjustments that many people find helpful: smaller portions more often rather than two or three large meals; eating slowly and stopping before feeling full; choosing lower-fat options for the first few days after each dose change; staying upright for at least an hour after eating; and staying well hydrated, taking small sips frequently rather than large amounts at once. None of these are prescriptions, they're sensible habits that reduce the load on a stomach that's already working hard.
If you're unsure whether what you're experiencing is typical, the nausea on Wegovy guide covers the expected pattern in more detail. If you've been wondering whether Wegovy can make you nauseous or have found yourself thinking Wegovy makes me nauseous, those pages go into the reasons behind it in more detail. Some people also notice that gassiness accompanies the nausea; if that's the case for you, the gassiness page covers that separately.
Most Wegovy-related nausea is unpleasant but not dangerous. There are situations, though, where you should get medical advice promptly rather than waiting it out.
If nausea is so severe that you cannot keep fluids down for more than a day, dehydration becomes a real concern, particularly in warm weather or if you are also experiencing diarrhoea or vomiting. Contact your prescriber or your GP. If you find that semaglutide is making you throw up alongside severe stomach pain that radiates towards your back, that pattern needs urgent attention: the MHRA's January 2026 Drug Safety Update on GLP-1 medicines flagged acute pancreatitis as a known, serious but infrequent risk, and the guidance is clear that this kind of pain warrants immediate medical assessment rather than waiting. You can also report any suspected side effects directly through the MHRA's Yellow Card scheme.
Nausea that simply doesn't improve after three to four weeks at a stable dose (not after a recent step up, but on a dose you've been taking for a month) is another reason to go back to your prescriber. It's possible the titration schedule needs slowing, or that something else is going on. Your prescriber can look at the whole picture. If you'd like a clinical review of how things are going, our clinical team is available seven days a week through aftercare.
Nausea in the early weeks is, for many people, the main reason they consider stopping Wegovy. That's understandable. But it's also one of the better-documented reasons that a slower titration often makes a significant difference. The standard schedule is a starting point, not a fixed rule, your prescriber can slow the pace of dose increases if nausea is making treatment genuinely difficult to sustain.
The NHS guidance on semaglutide recommends telling your doctor or pharmacist if any side effect is troubling you or doesn't go away. That's the right instinct. A decision made with clinical input (rather than alone, in a queasy moment) is far more likely to reach the right outcome.
If you're considering starting Wegovy or want to understand more about whether it's suitable for your situation, the semaglutide overview covers the full clinical picture, and a free consultation with our prescribers gives you a chance to ask all of this properly, with someone who can look at your individual history. Speak to our prescribers, that's what they're there for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.